SCHEMBL25328657

SCHEMBL25328657

CCc1cc(OCC(C)C)cc(CC)c1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.39
GABRB2 P47870 2/20 0.39
ALOX15 P16050 1/20 0.37
ALOX12 P18054 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HIF1A Q16665 1/20 0.37
FOS P01100 1/20 0.37
JUN P05412 1/20 0.37
PDK2 Q15119 1/20 0.36
XDH P47989 1/20 0.36
MAPT P10636 3/20 0.36
POLB P06746 1/20 0.36
HPGD P15428 1/20 0.36
XBP1 P17861 1/20 0.36
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25329864 0.90 ALDH1A1 (0.36) ALOX15ALOX12ALDH1A1HIF1AFOS
SCHEMBL25329142 0.80 ADRB2 (0.44) FOSJUNPDK2XDH
SCHEMBL25329709 0.79 GABRA1 (0.44) GABRA1GABRB2ALOX15ALOX12ALDH1A1
SCHEMBL25328339 0.76 GABRA1 (0.41) GABRA1GABRB2ALOX15ALOX12ALDH1A1
SCHEMBL25329716 0.76 LTA4H (0.46) GABRA1GABRB2CYP2C9
SCHEMBL25329694 0.76 CA1 (0.41) ALDH1A1MAPTPOLBHPGDXBP1
SCHEMBL25329412 0.75 ALDH1A1 (0.40) ALOX15ALOX12ALDH1A1HIF1AFOS
SCHEMBL5017375 0.74 GABRA1 (0.48) GABRA1GABRB2ALOX15ALOX12CYP1A2
SCHEMBL25329217 0.74 LTA4H (0.48) ALDH1A1MAPTNPC1TP53GAA
SCHEMBL19121047 0.74 ALDH1A1 (0.41) ALDH1A1FOSJUNPDK2XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12583813-B2 Polymerization inhibitors BASF SE (DE) 2026-03-24 US disclosed
US-20230242472-A1 POLYMERIZATION INHIBITORS BASF SE (DE) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242472-A1 POLYMERIZATION INHIBITORS RCE1, CABLES1, DPYD GABRA1 3598/4885GABRB2 2906/4885ALOX15 2186/4885
US-12583813-B2 Polymerization inhibitors PTGS1, PTGER1, POT1 GABRA1 1980/4885GABRB2 2597/4885ALOX15 615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.